75 related articles for article (PubMed ID: 3740864)
1. [Production of a cytotoxic factor into malignant pleural fluid by OK-423, a streptococcal preparation--kinetic analysis].
Yoshinaga T; Nomura H; Nishimura H; Tomino S; Kawakita M; Takatsuki K; Fujimoto K; Etou Y; Nakaji T; Kiyama T
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2675-7. PubMed ID: 3740864
[No Abstract] [Full Text] [Related]
2. [Induction of the human tumor necrosis factor (h-TNF) by the streptococcal preparation, OK-432--a clinical trial in 10 lung cancer patients with pleural fluid].
Miyai M; Matsuka Y; Tsubota T; Asano K
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1285-91. PubMed ID: 3782979
[No Abstract] [Full Text] [Related]
3. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 inducing activity of a streptococcal preparation OK-432 and its fractions by human monocytes.
Katsuta S; Kaneko Y; Tsutsui K; Tamaki S; Ibata H; Chen DR; Suzuki S; Natsuume-Sakai S; Yamamoto A
J Clin Lab Immunol; 1989 Mar; 28(3):129-36. PubMed ID: 2661826
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Kaneto E; Sasaki H; Tamura I; Kurimura O; Kurimura T
Biken J; 1983 Jun; 26(2):99-102. PubMed ID: 6318725
[TBL] [Abstract][Full Text] [Related]
6. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
7. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
[TBL] [Abstract][Full Text] [Related]
8. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
Watabe S; Sendo F; Kimura S; Arai S
J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
Kimura Y; Toki H; Okabe K; Fujii M; Tamai M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
[TBL] [Abstract][Full Text] [Related]
10. [In vivo augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432: characterization of effector cells and induction of interferon in sera (author's transl)].
Wakasugi H; Miyata M; Morioka Y; Oshimi K; Kasahara T; Takahashi K; Saito M; Ebina T
Nihon Gan Chiryo Gakkai Shi; 1981 Jun; 16(3):433-46. PubMed ID: 7320603
[No Abstract] [Full Text] [Related]
11. [Induction of mouse peritoneal cytotoxic factor by OK-432. (3). Comparison between LPS and OK-432 as eliciting agents].
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Nishii Y; Suzuki S; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2419-24. PubMed ID: 3729496
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
Oshimi K; Kano S; Takaku F; Okumura K
J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
[TBL] [Abstract][Full Text] [Related]
13. [Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor].
Kato M; Ishiwata D; Kakehi R; Oshima N; Soma G; Mizuno D
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2378-80. PubMed ID: 3606157
[TBL] [Abstract][Full Text] [Related]
14. [Induction of tumor necrosis factor (TNF) by OK-432].
Watanabe N; Sone H; Neda H; Niitsu Y; Urushizaki I
Gan No Rinsho; 1984 Aug; 30(10):1290-2. PubMed ID: 6481965
[TBL] [Abstract][Full Text] [Related]
15. [Definition of tumor-necrosis factor and its production mechanism].
Urushizaki I; Niitsu Y; Watanabe N
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
[TBL] [Abstract][Full Text] [Related]
16. Detection of tumour necrosis factor/cachectin in pleural effusion of patients with lung cancer.
Ishii Y; Uchiyama Y; Hasegawa S; Kinoshita T; Mitsui K; Kojima H; Fujita T
Clin Exp Immunol; 1990 Jun; 80(3):350-3. PubMed ID: 2372984
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
18. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
19. Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients.
Prado-Garcia H; Aguilar-Cazares D; Flores-Vergara H; Mandoki JJ; Lopez-Gonzalez JS
Lung Cancer; 2005 Mar; 47(3):361-71. PubMed ID: 15713519
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]